Spindle proteins in resected pancreatic head adenocarcinomas: BubR1 is an independent prognostic factor in pancreatobiliary-type tumours

Histopathology

Volumn 56, Issue 3, 2010, Pages 345-355

  Gladhaug, Ivar P ^a,b   Westgaard, Arne ^a,b   Schjølberg, Aasa R ^a,b   Burum Auensen, Espen ^a,b   Pomianowska, Ewa ^a,b   Clausen, Ole Petter F ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aurora A; BubR1; Mad2; Pancreatic cancer; Prognosis; Spindle proteins

Indexed keywords

AURORA A KINASE; BUB1 RELATED PROTEIN; PROTEIN MAD2;

ARTICLE; CANCER SURGERY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADENOCARCINOMA; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77449086261     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03489.x     Document Type: Article

References (51)

1. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann. Surg. 1998 227 821 831.
2. Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg. Clin. North Am. 2001 81 543 555.
3. Westgaard A, Tafjord S, Farstad IN et al. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer 2008 8 170.
4. Adsay NV, Basturk O, Cheng JD, Andea AA. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Semin. Radiat. Oncol. 2005 15 254 264.
5. Albores-Saavedra J, Henson DE, Klimstra DS Malignant epithelial tumors of the ampulla. In Rosai J, Sobin LH eds. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. Atlas of tumor pathology, third series, fascicle 27. Washington, DC : Armed Forces Institute of Pathology, 2000 259 316.
6. Kimura W, Futakawa N, Yamagata S et al. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn. J. Cancer Res. 1994 85 161 166.
7. Carpelan-Holmstrom M, Nordling S, Pukkala E et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry Gut 2005 54 385 387.
8. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998 396 643 649.
9. Jallepalli PV, Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat. Rev. Cancer 2001 1 109 117.
10. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 2007 8 379 393.
11. Suijkerbuijk SJ, Kops GJ. Preventing aneuploidy: the contribution of mitotic checkpoint proteins. Biochim. Biophys. Acta 2008 1786 24 31.
12. de Castro PI, de Cárcer G, Malumbres M. A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis 2007 28 899 912.
13. Rao CV, Yamada HY, Yao Y, Dai W Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice. Carcinogenesis 2009 30 1469 1474.
14. Barr AR, Gergely F. Aurora-A: the maker and breaker of spindle poles. J. Cell Sci. 2007 120 2987 2996.
15. Vader G, Lens SM. The Aurora kinase family in cell division and cancer. Biochim. Biophys. Acta 2008 1786 60 72.
16. Marumoto T, Zhang D, Saya H. Aurora-A - a guardian of poles. Nat. Rev. Cancer 2005 5 42 50.
17. Nishida N, Nagasaka T, Kashiwagi K, Boland CR, Goel A. High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers. Cancer Biol. Ther. 2007 6 525 533.
18. Baba Y, Nosho K, Shima K et al. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. Neoplasia 2009 11 418 425.
19. Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN Jr., Gandara DR. Aurora kinases as anticancer drug targets. Clin. Cancer Res. 2008 14 1639 1648.
20. Li D, Zhu J, Firozi PF et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin. Cancer Res. 2003 9 991 997.
21. Nowak NJ, Gaile D, Conroy JM et al. Genome-wide aberrations in pancreatic adenocarcinoma. Cancer Genet. Cytogenet. 2005 161 36 50.
22. Karhu R, Mahlamaki E, Kallioniemi A. Pancreatic adenocarcinoma - genetic portrait from chromosomes to microarrays. Genes Chromosomes Cancer 2006 45 721 730.
23. Sato N, Mizumoto K, Nakamura M et al. Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. Cancer Genet. Cytogenet. 2001 126 13 19. (Pubitemid 32421565)
24. Moskovitz AH, Linford NJ, Brentnall TA et al. Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma. Genes Chromosomes Cancer 2003 37 201 206.
25. Achille A, Baron A, Zamboni G et al. Molecular pathogenesis of sporadic duodenal cancer. Br. J. Cancer 1998 77 760 765.
26. Berkhout M, Nagtegaal ID, Cornelissen SJ et al. Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas. Mod. Pathol. 2007 20 1253 1262.
27. Chang MC, Chang YT, Tien YW, Sun CT, Wu MS, Lin JT. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization. Oncol. Rep. 2005 14 867 872.
28. Shiraishi K, Okita K, Kusano N et al. A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract and pancreas. Oncology 2001 60 151 161.
29. Westgaard A, Tafjord S, Farstad IN et al. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 2008 8 5.
30. Burum-Auensen E, de Angelis PM, Schjolberg AR, Kravik KL, Aure M, Clausen OP. Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry. J. Histochem. Cytochem. 2007 55 477 486.
31. Goldstein NS, Hewitt SM, Taylor CR, Yaziji H, Hicks DG. Recommendations for improved standardization of immunohistochemistry. Appl. Immunohistochem. Mol. Morphol. 2007 15 124 133.
32. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983 3 323 327.
33. Logarinho E, Bousbaa H. Kinetochore-microtubule interactions "in check" by Bub1, Bub3 and BubR1: the dual task of attaching and signalling. Cell Cycle 2008 7 1763 1768.
34. Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K, Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res. 2002 62 13 17.
35. Grabsch H, Takeno S, Parsons WJ et al. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer - association with tumour cell proliferation. J. Pathol. 2003 200 16 22.
36. Yamamoto Y, Matsuyama H, Chochi Y et al. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet. Cytogenet. 2007 174 42 47.
37. Van Deursen JM. Rb loss causes cancer by driving mitosis mad. Cancer Cell 2007 11 1 3.
38. Yuan B, Xu Y, Woo JH et al. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin. Cancer Res. 2006 12 405 410.
39. Wu CW, Chi CW, Huang TS. Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer. World J. Gastroenterol. 2004 10 3240 3244.
40. Li GQ, Li H, Zhang HF. Mad2 and p53 expression profiles in colorectal cancer and its clinical significance. World J. Gastroenterol. 2003 9 1972 1975.
41. Sotillo R, Hernando E, Díaz-Rodriguez E et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007 11 9 23.
42. Rojanala S, Han H, Munoz RM et al. The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer. Mol. Cancer Ther. 2004 3 451 457.
43. Burum-Auensen E, DeAngelis PM, Schjolberg AR, Roislien J, Mjaland O, Clausen OP. Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers. Cell Prolif. 2008 41 645 659.
44. Sen S, Zhou H, Zhang RD et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J. Natl Cancer Inst. 2002 94 1320 1329.
45. Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin. Cancer Res. 2004 10 2065 2071.
46. Burum-Auensen E, DeAngelis PM, Schjolberg AR, Roislien J, Andersen SN, Clausen OP. Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis. J. Clin. Pathol. 2007 60 1403 1408.
47. Landen CN Jr., Lin YG, Immaneni A et al. Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients. Clin. Cancer Res. 2007 13 4098 4104.
48. Tanaka E, Hashimoto Y, Ito T et al. The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin. Cancer Res. 2005 11 1827 1834. (Pubitemid 40471846)
49. Royce ME, Xia W, Sahin AA et al. STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis. Cancer 2004 100 12 19.
50. Lam AK, Ong K, Ho YH. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity. Hum. Pathol. 2008 39 599 604.
51. Rimkus C, Friederichs J, Rosenberg R, Holzmann B, Siewert JR, Janssen KP. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer. Int. J. Cancer 2007 120 207 211.